Sorafenib Versus Apatinib Both Combined Transarterial Chemoembolization for Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis: A Comparative Retrospective Study

OBJECTIVE: To compare the efficacy and safety of transarterial chemoembolization (TACE) combining with sorafenib or apatinib for hepatocellular carcinoma (HCC) patients with portal vein tumor thrombosis (PVTT). METHODS: From June 2015 to March 2020, a total of 89 consecutive advanced HCC patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Yanyan, Sun, Tao, Guo, Xiaopeng, Ouyang, Tao, Kan, Xuefeng, Chen, Lei, Liang, Bin, Wang, Mingfu, Zheng, Chuansheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369468/
https://www.ncbi.nlm.nih.gov/pubmed/34414104
http://dx.doi.org/10.3389/fonc.2021.673378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369468/
https://www.ncbi.nlm.nih.gov/pubmed/34414104
http://dx.doi.org/10.3389/fonc.2021.673378

Ejemplares similares